Found: 12
Select item for more details and to access through your institution.
Safety, Tolerability, and Pharmacodynamics of the ADAMTS‐5 Nanobody M6495: Two Phase 1, Single‐Center, Double‐Blind, Randomized, Placebo‐Controlled Studies in Healthy Subjects and Patients With Osteoarthritis.
- Published in:
- ACR Open Rheumatology, 2024, v. 6, n. 4, p. 205, doi. 10.1002/acr2.11610
- By:
- Publication type:
- Article
Multiple deletions in the polyketide synthase gene repertoire of Mycobacterium tuberculosis reveal functional overlap of cell envelope lipids in host-pathogen interactions.
- Published in:
- Cellular Microbiology, 2014, v. 16, n. 2, p. 195, doi. 10.1111/cmi.12214
- By:
- Publication type:
- Article
Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
- Published in:
- Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0294-x
- By:
- Publication type:
- Article
Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria -- quality of life (PKU-QOL) questionnaires.
- Published in:
- Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0261-6
- By:
- Publication type:
- Article
Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients’ and parents’ quality of life: the phenylketonuria – quality of life (PKU-QOL) questionnaires.
- Published in:
- Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 59, doi. 10.1186/s13023-015-0261-6
- By:
- Publication type:
- Article
Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Rv0180c contributes to Mycobacterium tuberculosis cell shape and to infectivity in mice and macrophages.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 11, p. 1, doi. 10.1371/journal.ppat.1010020
- By:
- Publication type:
- Article
Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009927
- By:
- Publication type:
- Article
Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis.
- Published in:
- Science Immunology, 2021, v. 6, n. 63, p. 1, doi. 10.1126/sciimmunol.abc2934
- By:
- Publication type:
- Article
Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2640, doi. 10.1111/cts.13658
- By:
- Publication type:
- Article
Natural mutations in the sensor kinase of the PhoPR two-component regulatory system modulate virulence of ancestor-like tuberculosis bacilli.
- Published in:
- PLoS Pathogens, 2023, v. 19, n. 7, p. 1, doi. 10.1371/journal.ppat.1011437
- By:
- Publication type:
- Article